Company Profile: AtriCure is a medical device company, which develops, manufactures and sells innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue.Current Share Price: $10.53 (Jan. 4) Potential Upside: 36% based on a $14 price target Barrington's Take: "We believe ATRC offers investors an appealing long-term growth story and is trading at an attractive valuation," the firm wrote. "In our opinion, there are few companies in our medical device universe that have greater growth opportunities than ATRC, which is why ATRC remains on our Best Ideas List at this point."
OraSure Technologies (OSUR) Company Profile: OraSure Technologies develops, manufactures and markets oral fluid diagnostic products and specimen collection devices. Current Share Price: $6.06 (Jan. 4) Potential Upside: 39% based on a price target of $8 Barrington's Take: OraSure gets selected for addition to Barrington's Best Ideas List as the company "offers investors an aggressive growth opportunity following the culmination of over four years of very heavy R&D investment totaling over $56 million." "We believe these shares will soon start reflecting the value of the company's new product pipeline as investors gain confidence in the company's progress toward obtaining FDA approval for its key new products," Barrington analysts wrote.